» Articles » PMID: 31593321

Goals of Care Discussions for Patients with Blood Cancers: Association of Person, Place, and Time with End-of-life Care Utilization

Overview
Journal Cancer
Publisher Wiley
Specialty Oncology
Date 2019 Oct 9
PMID 31593321
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Patients with blood cancers experience high-intensity medical care near the end of life (EOL) and low rates of hospice use; attributes of goals of care (GOC) discussions may partly explain these outcomes.

Methods: By using a retrospective cohort of patients with blood cancer who received care at Dana-Farber Cancer Institute and died in 2014, the authors assessed the potential relationship between timing, location, and the involvement of hematologic oncologists in the first GOC discussion with intensity of care near the EOL and timely hospice use.

Results: Among 383 patients, 39.2% had leukemia/myelodysplastic syndromes, 37.1% had lymphoma, and 23.7% had myeloma. Overall, 65.3% of patients had a documented GOC discussion. Of the first discussions, 33.2% occurred >30 days before death, 34.8% occurred in the outpatient setting, and 46.4% included a hematologic oncologist. In multivariable analyses, having the first discussion >30 days before death (odds ratio [OR], 0.37; 95% CI, 0.17-0.81), in the outpatient setting (OR, 0.21; 95% CI, 0.09-0.50), and having a hematologic oncologist present (OR, 0.40; 95% CI, 0.21-0.77) were associated with lower odds of intensive care unit admission ≤30 days before death. The presence of a hematologic oncologist at the first discussion (OR, 3.07; 95% CI, 1.58-5.96) also was associated with earlier hospice use (>3 days before death).

Conclusions: In this large cohort of blood cancer decedents, most initial GOC discussions occurred close to death and in the inpatient setting. When discussions were timely, outpatient, or involved hematologic oncologists, patients were less likely to experience intensive health care use near death and were more likely to enroll in hospice.

Citing Articles

Challenges in hospice and end-of-life care in the transfusion-dependent patient.

Rodenbach R, Caprio T, Loh K Hematology Am Soc Hematol Educ Program. 2024; 2024(1):340-347.

PMID: 39644067 PMC: 11665515. DOI: 10.1182/hematology.2024000560.


Compassionate Communication and Advance Care Planning to improve End-of-life Care in Treatment of Haematological Disease 'ACT': Study Protocol for a Cluster-randomized trial.

Myrhoj C, Clemmensen S, Jarden M, Johansen C, Von Heymann A BMJ Open. 2024; 14(5):e085163.

PMID: 38772898 PMC: 11110583. DOI: 10.1136/bmjopen-2024-085163.


Cost of Hospitalization Associated with Inpatient Goals-of-Care Program Implementation at a Comprehensive Cancer Center: A Propensity Score Analysis.

Hui D, Huang Y, Andersen C, Cassel B, Nortje N, George M Cancers (Basel). 2024; 16(7).

PMID: 38610994 PMC: 11010830. DOI: 10.3390/cancers16071316.


Perspectives of Patients With Relapsed and Refractory Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome on Patient-Clinician Communication About Prognosis and the Future.

Rao V, Linsky S, Knobf M Palliat Med Rep. 2024; 5(1):53-62.

PMID: 38249836 PMC: 10797310. DOI: 10.1089/pmr.2023.0064.


End-of-Life Care of Acute Myeloid Leukemia Compared with Aggressive lymphoma in Patients Who Are Eligible for Intensive Chemotherapy: An Observational Study in a Japanese Community Hospital.

Kokaji M, Imoto N, Watanabe M, Suzuki Y, Fujiwara S, Ito R Palliat Med Rep. 2023; 4(1):71-78.

PMID: 36960234 PMC: 10029750. DOI: 10.1089/pmr.2022.0056.


References
1.
Dans M, Smith T, Back A, Baker J, Bauman J, Beck A . NCCN Guidelines Insights: Palliative Care, Version 2.2017. J Natl Compr Canc Netw. 2017; 15(8):989-997. DOI: 10.6004/jnccn.2017.0132. View

2.
Narang A, Wright A, Nicholas L . Trends in Advance Care Planning in Patients With Cancer: Results From a National Longitudinal Survey. JAMA Oncol. 2015; 1(5):601-8. PMC: 4537325. DOI: 10.1001/jamaoncol.2015.1976. View

3.
Mack J, Weeks J, Wright A, Block S, Prigerson H . End-of-life discussions, goal attainment, and distress at the end of life: predictors and outcomes of receipt of care consistent with preferences. J Clin Oncol. 2010; 28(7):1203-8. PMC: 2834470. DOI: 10.1200/JCO.2009.25.4672. View

4.
Odejide O, Cronin A, Earle C, LaCasce A, Abel G . Hospice Use Among Patients With Lymphoma: Impact of Disease Aggressiveness and Curability. J Natl Cancer Inst. 2015; 108(1). DOI: 10.1093/jnci/djv280. View

5.
Gilligan T, Coyle N, Frankel R, Berry D, Bohlke K, Epstein R . Patient-Clinician Communication: American Society of Clinical Oncology Consensus Guideline. J Clin Oncol. 2017; 35(31):3618-3632. DOI: 10.1200/JCO.2017.75.2311. View